Loading clinical trials...
Loading clinical trials...
Canadian Assessment of the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
Conditions
Start Date
July 1, 2006
Primary Completion Date
August 1, 2009
Completion Date
August 1, 2009
Last Updated
March 18, 2014
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions